vs
Maase Inc.（MAAS）与MediWound Ltd.（MDWD）财务数据对比。点击上方公司名可切换其他公司
Maase Inc.的季度营收约是MediWound Ltd.的1.7倍（$9.9M vs $5.7M）
MediWound Ltd.是一家聚焦烧伤护理、慢性创面治疗及软组织修复领域的生物制药企业，研发、生产及销售创新创面护理产品，主要面向北美、欧洲及亚洲市场的医院、医疗机构及患者提供服务。
MAAS vs MDWD — 直观对比
营收规模更大
MAAS
是对方的1.7倍
$5.7M
损益表 — Q2 FY2023 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.9M | $5.7M |
| 净利润 | — | $-13.3M |
| 毛利率 | 78.7% | 23.5% |
| 营业利润率 | -55.9% | -100.1% |
| 净利率 | — | -233.3% |
| 营收同比 | — | 12.7% |
| 净利润同比 | — | -111.2% |
| 每股收益（稀释后） | — | $-1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MAASMDWD
| Q2 25 | — | $5.7M | ||
| Q2 24 | — | $5.1M | ||
| Q2 23 | — | $4.8M | ||
| Q4 22 | $9.9M | — | ||
| Q2 22 | — | $4.7M |
净利润MAASMDWD
| Q2 25 | — | $-13.3M | ||
| Q2 24 | — | $-6.3M | ||
| Q2 23 | — | $916.0K | ||
| Q4 22 | — | — | ||
| Q2 22 | — | $-4.4M |
毛利率MAASMDWD
| Q2 25 | — | 23.5% | ||
| Q2 24 | — | 8.8% | ||
| Q2 23 | — | 23.8% | ||
| Q4 22 | 78.7% | — | ||
| Q2 22 | — | 23.8% |
营业利润率MAASMDWD
| Q2 25 | — | -100.1% | ||
| Q2 24 | — | -88.6% | ||
| Q2 23 | — | -84.0% | ||
| Q4 22 | -55.9% | — | ||
| Q2 22 | — | -78.7% |
净利率MAASMDWD
| Q2 25 | — | -233.3% | ||
| Q2 24 | — | -124.5% | ||
| Q2 23 | — | 19.2% | ||
| Q4 22 | — | — | ||
| Q2 22 | — | -93.3% |
每股收益（稀释后）MAASMDWD
| Q2 25 | — | $-1.23 | ||
| Q2 24 | — | $-0.68 | ||
| Q2 23 | — | $0.10 | ||
| Q4 22 | — | — | ||
| Q2 22 | — | $-0.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.9M | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $31.6M | $20.1M |
| 总资产 | $47.0M | $67.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MAASMDWD
| Q2 25 | — | $1.1M | ||
| Q2 24 | — | $3.8M | ||
| Q2 23 | — | $19.2M | ||
| Q4 22 | $10.9M | — | ||
| Q2 22 | — | $7.7M |
股东权益MAASMDWD
| Q2 25 | — | $20.1M | ||
| Q2 24 | — | $17.9M | ||
| Q2 23 | — | $34.9M | ||
| Q4 22 | $31.6M | — | ||
| Q2 22 | — | $-2.2M |
总资产MAASMDWD
| Q2 25 | — | $67.0M | ||
| Q2 24 | — | $57.3M | ||
| Q2 23 | — | $64.4M | ||
| Q4 22 | $47.0M | — | ||
| Q2 22 | — | $21.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.2M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $-18.3M | — |
| 自由现金流率自由现金流/营收 | -184.4% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MAASMDWD
| Q2 25 | — | $-5.8M | ||
| Q2 24 | — | $-3.6M | ||
| Q2 23 | — | $-5.3M | ||
| Q4 22 | $-18.2M | — | ||
| Q2 22 | — | $-5.3M |
自由现金流MAASMDWD
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | $-18.3M | — | ||
| Q2 22 | — | — |
自由现金流率MAASMDWD
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | -184.4% | — | ||
| Q2 22 | — | — |
资本支出强度MAASMDWD
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | 1.0% | — | ||
| Q2 22 | — | — |
现金转化率MAASMDWD
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | -5.73× | ||
| Q4 22 | — | — | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAAS
| Wealth management | $7.8M | 78% |
| Insurance consulting | $1.0M | 10% |
| Other | $975.0K | 10% |
| Asset management | $168.0K | 2% |
MDWD
暂无分部数据
